At Nomisma Healthcare Pvt Ltd. , We are Working on advanced Research on Bioabsorbable polymers and provide our service to the globe.

PLGA (Poly(lactide-co-glycolide), PLA (Polylactide), and PEG-PLGA Block polymers are some of them.

These polymers are well-established and accepted by FDA as Bioabsorbable polymers for their use in medical devices and drug delivery applications.

Our Mission is to Provide Polymers for Parenteral Controlled Release Drug Delivery & Medical Devices without compromising quality aspects and not much affecting the project economy.

Nomisma Healthcare is one of the world’s leading specialty polymers manufacturer and supplier companies. Serving customers in consumer and industrial markets. The keen, passionate, well-knowledge staff is committed to providing practical, innovative, and elegant solutions to customers in more than 100 countries/regions to meet the complex requirements of various polymers’ grades. We are enthusiastic to learn and implement the growing technology to enhance the process potentials of our customers by providing the choice of product/s of important requirement, without affecting the natural resources which in turn maintain the quality life of human beings. Through the knowledge and applicability – our people, products, and services to the customers across the globe – Nomisma healthcare continues to expand its services with renewable and sustainable solutions.

A key feature of Nomisma healthcare’s bioresorbable polymers is that they contain no detectable residual solvents, reducing concern over potential effects due to solvent/s. Additionally, all bioresorbable polymers meet typical drug and device regulatory thresholds for tin metal levels, established by health authorities, with significantly lower levels than regulatory requirements.

Manufacturing and supplying of PLGA (Poly(lactide-co-glycolide), PLA (Polylactide), and PEG-PLGA Block polymers are our main Portfolio.

N

Bioresorbable Polymers

Nomisma Healthcare offers bioresorbable polymers for Parenteral Controlled Release Drug Delivery Systems & Medical Devices.

N

Expert Staff

More than 25 years of experience in the field of polymer chemistry & Pharmaceutical chemistry. Good knowledge of cGMP, 21 CFR, and Other regulatory aspects

N

Fast Delivery time

dispatching the consignment within 2 to 4 weeks after the order is confirmed.

N

Raise Quality Standards

Through the knowledge and applicability – our people, products, and services to the customers across the globe – Nomisma continues to expand its services with renewable and sustainable solutions

N

Walk-In's Accepted

We are the world’s polymer supplier to support pharmaceutical and medical applications for which projects can be well established with minimal effect in the project economy when polymer usage is considered as one of the ingredients.

N

Low tin metal level

All bioresorbable polymers meet typical drug and device regulatory thresholds for tin metal levels established by health authorities with significantly lower tin metal levels than regulatory requirements.

Our Products

Nomisma offers bioresorbable / Biodegradables polymers as an excipient in Parenteral Controlled Release Drug Delivery Systems & row material for Medical Devices.

Our price is starting from 3.3 USD to 4.8 USD per unit gram for the various range of polymers.

Drug Delivery

      • Formulation developers are using self-absorbable polymers to create drug delivery systems that improve the patient’s health. Flexibility, convenience and better compliance to meet patient needs can all be incorporated into the system design process involving the use of Proteins, vaccines, and other biological molecules. Scientists can use our polymer to develop & manufacture strategies of controlled release injectable depots, micro/nanoparticles, and solid implants. API together with polymer and solvent is mixed to form a gel which is injected into the patient so that the drug can release as per necessity.
  • Poly (D, L-Lactide) (PDLLA)
  • Poly (D, L-Lactide-co-Glycolide) (PLGA)
  • Poly (D, L-Lactide-co-Glycolide-co-PEG) (PLGA-PEG-PLGA).
PLGA

Medical Devices

Bioresorbable Polymers are valuable additives inside the design and manufacture of Medical Devices such as:
Screws
Plates and Bone regeneration scaffolds
Staples and Sutures
Neural conduits
Hernia meshes
Stents
Device coatings
Dental and Ophthalmic treatments

  • Poly(L-Lactide) (PLLA)
  • Poly(ɛ-Caprolactone) (PCL)
  • Poly(L-Lactide-co-ɛ-Caprolactone) (PLCL).
  • Poly(Glycolide) (PGA)
PLGA

Poly (D, L-Lactide-co-Glycolide) (PLGA)

Synonym: PLGA, Poly(D,L-lactide-co-glycolide) ,Poly(DL-lactide-co-glycolide), PGLA

CAS Number: 26780-50-7

 The ratio of Lactide and Glycolide: PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45, PLGA 45:55, PLGA 55:45 Star Glucose, PLGA 90:10, PLGA 10:90, Or any custom ratio of La and GA.

Inherent viscosity (IV.) range: 0.15 dg/L to 2.3 dg/L

End Group: Acid terminated, Ester terminated, Hydroxy terminated, etc.

Poly (D, L-Lactide) (PDLLA)

Synonym: Polylactic acid, Poly(L-lactide), Poly(D,L-lactide) , Poly(D-lactide), PLA, PLLA, PDLA, PDA, PDLLA etc.

CAS Number: 33135-50-1

 The ratio of L Lactide and D-Lactide: PLLA 100: 00, PDLLA 50:50, PDLLA 75:25 ,PDLLA25:75 , PDLA 00:100 etc.

Inherent viscosity (IV.) range: 0.15 dg/L to 2.3 dg/L

End Group: Acid terminated, Ester terminated, Hydroxy terminated, etc.

PLGA

Other Polymers

All bioresorbable polymers can be custom produced with defined Chemical Structures, Molar Masses (Molecular Weight or Inherent Viscosity) & Selective Terminal End groups. some are as below

  •  Poly (D, L-Lactide-co-Glycolide-co-PEG) (PLGA-PEG-PLGA)
  • Poly(ɛ-Caprolactone) (PCL)
  • Poly(L-Lactide-co-ɛ-Caprolactone) (PLCL).
  • Poly(Glycolide) (PGA),
  • PLGA-NH2
  • M-PEG-OH
  • M-PEG-PLGA
  • M-PEG-NH2
  • Polyaniline